Regenix Biosciences Limited

Regenix Biosciences Limited - healthcare in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U24100TN2006PLC059065 Incorporated 02 March 2006 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Public Limited Company healthcare MSME · Micro
Data last updated
Revenue · FY 2025
₹6.81 Cr
▲ 65% YoY
Net loss · FY 2025
₹51.82 Lakh
Net margin -7.6%
EBITDA · FY 2025
₹1.3 Cr
EBITDA margin 19.1%
Authorised capital
₹16 Cr
Registered with MCA
Paid-up capital
₹15.99 Cr
Issued & subscribed
Open charges
₹14.7 Cr
Satisfied ₹8.7 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
38
Provident fund records

About Regenix Biosciences Limited

Data last updated:

Regenix Biosciences Limited is a public limited company based in Chennai, Tamil Nadu, India, a subsidiary of Regenix Drugs Limited. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 02 March 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2006PLC059065. Its GSTIN is 33AABCL1653Q1ZB (Tamil Nadu).

The company has an authorised share capital of ₹16 Cr and a paid-up capital of ₹15.99 Cr. It was formerly known as Liv Medica Equipments Private Limited and Liv Medica Equipments Limited. It is led by directors including Ramamurthy Ayyavuthevar (Managing Director) and Malathi Ramamurthy.

Its last annual general meeting (AGM) was held on 22 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Jamal Sonu Terrace 42/1 Loganathan Nagar First Street 100 Feet Road Choolaimedu, Chennai, Tamil Nadu, India – 600094.

As per the financials filed for FY 2025, the company reported a revenue of ₹6.81 Cr, a growth of 65% compared to the previous year. For the same year it recorded a net loss of ₹51.82 Lakh (net margin -7.6%) and EBITDA of ₹1.3 Cr (EBITDA margin 19.1%). Revenue has grown at a compounded annual rate (CAGR) of 90% over three years and 41% over five years.

The company has about 38 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹14.7 Cr and satisfied charges of ₹8.7 Cr on record.

Regenix Biosciences Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0033614). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website livmedica.in.

Company details

CIN U24100TN2006PLC059065
Registration Number 059065
Incorporation Date 02 March 2006
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 22 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Regenix Drugs Limited
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0033614

Name history

Regenix Biosciences has undergone 2 name changes throughout its history. The company was previously known as Liv Medica Equipments Private Limited, and Liv Medica Equipments Limited. The current legal name is Regenix Biosciences Limited.

Company NameStatus
Regenix Biosciences LimitedCurrent
Liv Medica Equipments Private LimitedPrevious
Liv Medica Equipments LimitedPrevious

CIN history

Regenix Biosciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100TN2006PLC059065, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24100TN2006PLC059065Current
U33119TN2006PTC059065Previous
U33119TN2006PLC059065Previous
Key People
Ramamurthy Ayyavuthevar Managing Director Krishanamoorthy Nirosha Cfo Malathi Ramamurthy Director

Recognitions & Rankings of Regenix Biosciences

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-TN-02-0033614

Contact details

Regenix Biosciences Limited's registered office is in Chennai, Tamil Nadu. Its website is livmedica.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    livmedica.in
  • Registered Address
    Jamal Sonu Terrace 42/1 Loganathan Nagar First Street 100 Feet Road Choolaimedu, Chennai, Tamil Nadu, India – 600094
  • Industry
    Healthcare, Medical Consumables & Supplies

To see the full contact details of Regenix Biosciences Limited, buy the company report.

Comprehensive company report
Regenix Biosciences Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Regenix Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Regenix Biosciences Limited, buy the company report.

Financials of Regenix Biosciences Limited

FY 2024 filings available

Regenix Biosciences Limited reported revenue of ₹6.81 Cr (up 65% YoY) for FY 2025.

Revenue · FY 2025
₹6.81 Cr ▲ 65%
Net loss · FY 2025
₹51.82 Lakh margin -7.6%
EBITDA · FY 2025
₹1.3 Cr margin 19.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 65%
3 years · compounded
▲ 90%
5 years · compounded
▲ 41%
EBITDA CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 181%
5 years · compounded
▲ 70%

Revenue has grown at a compounded annual rate (CAGR) of 41% over five years, including 65% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.3 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹51.82 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin19.1%
Net Profit Margin-7.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Regenix Biosciences Limited, buy the company report.

Board of directors and KMP of Regenix Biosciences Limited

Regenix Biosciences Limited currently reports 10 directors and 2 key managerial personnel. 12 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Malathi Ramamurthy
Also directs: Regenix Drugs Limited, Regenix Super Speciality Laboratories Private Limited
Director29 Sep 200719 Years 1 MonthsCurrent
Manjit Singh ParmarDirector01 May 20197 Years 6 MonthsCurrent
Krishanamoorthy Nirosha
Also directs: Regenix Drugs Limited
Cfo01 May 20197 Years 6 MonthsCurrent
Balaji Ramamurthy
Also directs: Regenix Drugs Limited
Director24 Sep 20233 Years 1 MonthsCurrent
Odaian Maniraj AmbalamDirector11 Dec 200718 Years 10 MonthsCurrent
RukmaniDirector01 May 20197 Years 6 MonthsCurrent
Showing 6 of 12 current directors and KMP. View all directors and KMP

Auditor

Regenix Biosciences Limited is audited by J.THOMAS FERNANDO & CO for the financial year 2024.

Auditor firmFinancial yearFirm registration number
J.THOMAS FERNANDO & COFY 2024004402S

Shareholding

The shareholding of Regenix Biosciences Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Regenix Biosciences Limited, buy the company report.

Charges & borrowings

Open charges
₹14.7 Cr
Satisfied charges
₹8.7 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹14.50 Cr
Central Bank of India₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Oct 2021100505987Hdfc Bank Limited₹14.5 CrOpen
16 Jun 198390382524Central Bank of India₹20 LakhOpen
18 Aug 200610017707Uti Bank Limited₹8.7 CrSatisfied

To see the full charge records of Regenix Biosciences Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Regenix Biosciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Regenix Biosciences Limited has a workforce of 38 employees on its EPFO records as of Apr 13, 2025, across 1 active EPFO establishment.

Employee count
38
Active EPFO establishments
1
Employee growth
31.03%

GST

Regenix Biosciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AABCL1653Q1ZBTamil NaduActive01 Jul 2017

To see the full GST registrations and return filing status of Regenix Biosciences Limited, buy the company report.

Recent activity

Regenix Biosciences Limited has 24 board changes on record since 2006: 12 appointments and 12 cessations. The latest: Balaji Ramamurthy was appointed as Director on 24 Sep 2023.

AGM
Regenix Biosciences Limited last Annual general meeting of members was held on 22 Sep 2024 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 14.50 Cr registered on 18 Oct 2021 with Charge ID 100505987 was modified on 03 Apr 2024.
Filing
Regenix Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Appointed
Balaji Ramamurthy was appointed as Director.
Ceased
Manjit Singh Parmar ceased to be Director.
Ceased
Rukmani ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 14.50 Cr with Charge ID 100505987 was registered on 18 Oct 2021.
Ceased
Ashish Anil Vora ceased to be Additional Director.
Ceased
Ramamurthy Ayyavuthevar ceased to be Managing Director.
Appointed
Ashish Anil Vora was appointed as Director.
Appointed
Krishanamoorthy Nirosha was appointed as CFO.
Appointed
Manjit Singh Parmar was appointed as Director.

21 earlier events are in the company report.

Frequently asked questions

Regenix Biosciences is an active public limited company based in Chennai, Tamil Nadu, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 02 March 2006 (20+ years old) and is registered under CIN U24100TN2006PLC059065.

Regenix Biosciences has 12 current directors and KMP:

The latest financial statements of Regenix Biosciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 22 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Regenix Biosciences is 33AABCL1653Q1ZB, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Regenix Biosciences is U24100TN2006PLC059065. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Regenix Biosciences was incorporated on 02 March 2006, making it 20+ years old. It is registered with the Registrar of Companies, Chennai.

Balaji Ramamurthy was appointed as Director on 24 Sep 2023. Manjit Singh Parmar ceased to be Director on 30 Apr 2022. Rukmani ceased to be Director on 30 Apr 2022. Regenix Biosciences has 24 board changes on record in total.

Yes, Regenix Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0033614).

Regenix Biosciences can be reached through the website livmedica.in. Its registered office is in Chennai, Tamil Nadu, India.

The registered office of Regenix Biosciences is at Jamal Sonu Terrace 421 Loganathan Nagar First Street 100 Feet Road Choolaimedu, Chennai, Tamil Nadu, India – 600094.